Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. - Wikidata - wikimedia - TriplyDB

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

http://www.wikidata.org/entity/Q34160683

about

Optimizing treatments for lymphangioleiomyomatosis Lymphangioleiomyomatosis: differential diagnosis and optimal management Management of lymphangioleiomyomatosis Lymphangioleiomyomatosis: an explosive presentation of a rare disease.Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside.Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations Lymphangioleiomyomatosis: what do we know and what are we looking for?Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis Lymphangioleiomyomatosis and tuberous sclerosis complex.A case of lymphangioleiomyomatosis originated in the pelvic cavity.Surgical treatment of chylothorax caused by lymphangioleiomyomatosis The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.Lymphangioleiomyomatosis: New Treatment Perspectives.In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis.Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.Lymphangioleiomyomatosis suspected to be a gynecologic disease.

P2860

Q26865250-2FEB6D6E-99D7-430A-A1B9-5321847BF0C3 Q27022412-43D317B5-16E5-44CC-B2D9-90256B81FD45 Q28084725-51299192-F857-465E-8D17-0E0B2B1857C1 Q33770723-E6DE341F-D44E-443E-93B0-D4C74F4DB110 Q33823877-86FBBB67-F3E1-456F-A70D-716CF28CB515 Q34079459-159AFB06-1A93-4477-8475-D03C50CFE613 Q34167429-42C26963-B63F-4DB3-8EF3-023FF653EE17 Q34204852-EC9F888F-7A9B-4B8B-B821-D385B508F815 Q34536450-055E4903-3C8B-4D1F-B6F5-FDA7AB533755 Q34560457-9911FBBE-640A-4E2E-B8DF-B36D6DF0DCDA Q35049412-2D5778A1-03EB-49E2-AD2D-DE824A0E45BA Q35971499-47A4F263-C4FB-4EFF-B794-409A966B4FC5 Q36067383-5578F04A-0F2D-444A-A787-A596BEA4EB90 Q36293927-3B597F47-F97F-4C29-8701-1E58BC406298 Q37137669-A53DF3F1-5575-470E-B6CB-86250976B070 Q37177680-A48BF38D-1F81-43E2-88BD-02747407BED9 Q37620536-F1554887-C4D8-4F7F-9700-E8D88AC68259 Q38372196-1888B115-4EB7-4764-A628-353C84452F92 Q38484497-5B5BB4BD-F4D3-4264-9F0D-6A9B67DD0E05 Q42645301-D917B42B-CAB8-444F-8C94-F445D7CEBC03 Q44135736-8F33554C-4774-4DE4-9633-41EB5A3915BF Q48355779-D47CB2A6-AD13-4F4B-B6BB-F4010A0EBE53 Q51505244-7970A9C0-5D84-4D3E-A0CC-A683EEF7A97E

P2860

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

http://www.wikidata.org/entity/Q34160683

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@ast

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@en

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@nl

type

label

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@ast

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@en

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@nl

prefLabel

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@ast

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@en

Effect of a gonadotrophin-rele ...... n in lymphangioleiomyomatosis.

@nl

P1433

Q34160683-260E727C-2277-4895-AC67-32ACC7603A20

P1476

Q34160683-FE1491F9-F86C-4404-AA77-E828B9D6F7B1

P2093

Q34160683-1B6E7603-9D51-4906-8311-F895801AB92D

Q34160683-7AA9EACB-9940-4694-A95C-996FC863492D

Q34160683-82E541CB-6595-4470-B910-74FBD811F970

Q34160683-84830B63-754B-4C76-905B-766254EFDD73

P2860

Q34160683-1547DC61-25E0-4EA1-AAE8-632F75CA1E28

Q34160683-1999A74B-45DE-4B74-A287-C831EB5C481D

Q34160683-1DCDE486-6B2A-4E3F-972A-DA25914D553B

Q34160683-23830D4B-4A38-4EE9-A80F-A9781AFD1A7F

Q34160683-44AFC36C-B58F-48A9-B780-467320910B33

Q34160683-5862657D-6503-4174-B283-4B45C27AE502

Q34160683-5D5DB1FD-768D-48FB-9084-418F46A7C45F

Q34160683-60D1964D-E43E-44CA-89D8-F5CDD672B3A3

Q34160683-694FBCF2-8D77-4EF1-81E5-B8E9986A6111

Q34160683-83533E9A-BF1A-4111-8126-340BBD943BFA

P304

Q34160683-797F3AA2-4940-4FD9-B985-378B745129D1

P31

Q34160683-384C665D-04C5-4A51-8289-B439B24EFD58

P356

Q34160683-3388049D-BE5E-4FDE-A784-8F34061CFBB4

P407

Q34160683-B7378ED6-4CDC-45FA-AA74-5155342EA301

P433

Q34160683-F84F6788-2921-4E86-B67C-A036D73FD175

P478

Q34160683-1D55A58A-B562-4038-9A2D-579C41D593CA

P50

Q34160683-3A6A3321-C57E-4C61-840A-3DBBECEBCEC8

P577

Q34160683-7957BC8A-3276-4133-84B6-160E0FBA993E

P5875

Q34160683-07AE5E29-8815-4D8C-9A41-D98A64F9F9E0

P698

Q34160683-629C8A89-6A3B-4265-AB7A-7B55253D1DEB

P932

Q34160683-01FABB57-8C52-4391-982D-F4D7D1B56E3D

P356

P1433

P1476

Effect of a gonadotrophin-rele ...... on in lymphangioleiomyomatosis

@en

P2093

Angelo M Taveira-DaSilva

http://www.w3.org/2001/XMLSchema#string

Iacopo Chiodini

http://www.w3.org/2001/XMLSchema#string

Joel Moss

http://www.w3.org/2001/XMLSchema#string

Roberto Cassandro

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

Standardization of Spirometry, 1994 Update. American Thoracic Society

Lymphangioleiomyomatosis: abdominopelvic CT and US findings.

Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.

Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.

Clinical experience of lymphangioleiomyomatosis in the UK.

Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment.

Effect of encouragement on walking test performance.

Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.

P304

448-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.07-2277

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5777392

http://www.w3.org/2001/XMLSchema#string

P698

18071009

http://www.w3.org/2001/XMLSchema#string

P932

2946894

http://www.w3.org/2001/XMLSchema#string